Half-year report · Q2
4937.TEDINET S100VR3K
Period2024-10-01 → 2025-03-31
Filed2025-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥835m | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥1.9bn | 2023-10-01 → 2024-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥934m | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Operating income | −¥52m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | −¥87m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | −¥55m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥57m | 2023-10-01 → 2024-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥84m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Profit before tax | −¥55m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥84m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥59m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥17m | 2023-10-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥111m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥59m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | −¥111m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥3.0bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥3.1bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥3.1bn | at 2024-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥964m | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥993m | at 2024-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥2.1bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.1bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥2.0bn | at 2024-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.3bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.3bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2023-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥10m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥49m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥67m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥88m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥76m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥12m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥123m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥112m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥130m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-16.36 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.03 | 2023-10-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-33.54 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 67.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.2% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥187m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥503m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥503m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥144m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥332m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥332m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥9m |
| —segment total | revenue | 2024-10-01 → 2025-03-31 | ¥835m |
| —segment total | revenue external | 2024-10-01 → 2025-03-31 | ¥835m |
| —segment total | segment profit | 2024-10-01 → 2025-03-31 | ¥135m |
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-03-31 | −¥75,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-03-31 | −¥75,000 |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥200m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥712m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥712m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥75,000 |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥154m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥222m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥222m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥42m |
| —segment total | revenue | 2023-10-01 → 2024-03-31 | ¥934m |
| —segment total | revenue external | 2023-10-01 → 2024-03-31 | ¥934m |
| —segment total | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥75,000 |
| —segment total | segment profit | 2023-10-01 → 2024-03-31 | ¥113m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 432
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | － | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -85930000 | JPY |
| Payments of loans receivable inv cf | Prior1YTDDuration | -24898000 | JPY |
| Payments of loans receivable inv cf | CurrentYTDDuration | － | JPY |
| Proceeds on transfer or receivables inv cf | Prior1YTDDuration | 35803000 | JPY |
| Proceeds on transfer or receivables inv cf | CurrentYTDDuration | － | JPY |
| Payments for lease and guarantee deposits inv cf | Prior1YTDDuration | － | JPY |
| Payments for lease and guarantee deposits inv cf | CurrentYTDDuration | -3323000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | 11505000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -88054000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YTDDuration | 20000000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYTDDuration | － | JPY |
| Proceeds from long term loans payable fin cf | Prior1YTDDuration | 200000000 | JPY |
| Proceeds from long term loans payable fin cf | CurrentYTDDuration | 74000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -94814000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -91920000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | － | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -19831000 | JPY |
| Decrease increase in deposits for purchase of treasury shares fin cf | Prior1YTDDuration | － | JPY |
| Decrease increase in deposits for purchase of treasury shares fin cf | CurrentYTDDuration | -84950000 | JPY |
| Other net fin cf | Prior1YTDDuration | 5215000 | JPY |
| Other net fin cf | CurrentYTDDuration | － | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | 130401000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -122701000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 74415000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -200802000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 1305025000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1505331000 | JPY |
| Increase in cash and cash equivalents resulting from share exchanges | Prior1YTDDuration | 115059000 | JPY |
| Increase in cash and cash equivalents resulting from share exchanges | CurrentYTDDuration | － | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 1494500000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 1304528000 | JPY |
| Payrolls and allowances etc sga | Prior1YTDDuration | 143870000 | JPY |
| Payrolls and allowances etc sga | CurrentYTDDuration | 200534000 | JPY |
| Advertising expenses selling expenses | Prior1YTDDuration | 196324000 | JPY |
| Advertising expenses selling expenses | CurrentYTDDuration | 80594000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E36697-000DirectToConsumerBusinessReportableSegmentMember | 712366000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E36697-000MedicalSupportReportableSegmentMember | 221969000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 934335000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 934335000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E36697-000DirectToConsumerBusinessReportableSegmentMember | 75000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E36697-000MedicalSupportReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 75000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -75000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E36697-000DirectToConsumerBusinessReportableSegmentMember | 712441000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E36697-000MedicalSupportReportableSegmentMember | 221969000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 934411000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -75000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |